FDA Approved: KALYDECO — Original Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

The FDA approved KALYDECO (ivacaftor) through an original application for the treatment of cystic fibrosis in patients with specific CFTR gating mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Kalydeco (ivacaftor)

Snippet

ORIG AP for KALYDECO (IVACAFTOR)